Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 209.17M P/E - EPS this Y -22.60% Ern Qtrly Grth -
Income -88.56M Forward P/E -2.73 EPS next Y 2.40% 50D Avg Chg -19.00%
Sales - PEG -0.23 EPS past 5Y - 200D Avg Chg 28.00%
Dividend N/A Price/Book 2.01 EPS next 5Y 13.10% 52W High Chg -35.00%
Recommedations 1.60 Quick Ratio 9.30 Shares Outstanding 67.10M 52W Low Chg 379.00%
Insider Own 0.51% ROA -37.87% Shares Float 35.02M Beta 1.52
Inst Own 97.74% ROE -88.56% Shares Shorted/Prior 3.93M/3.96M Price 4.75
Gross Margin - Profit Margin - Avg. Volume 617,506 Target Price 19.00
Oper. Margin - Earnings Date Nov 5 Volume 604,578 Change -5.38%
About Inozyme Pharma, Inc.

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, as well as patients with end-stage kidney disease receiving hemodialysis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Inozyme Pharma, Inc. News
11/27/24 Inozyme Pharma to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/13/24 Here's Why Inozyme Pharma (INZY) is Poised for a Turnaround After Losing -29.98% in 4 Weeks
11/11/24 Inozyme Pharma to Present at Upcoming Investor Conferences
11/05/24 Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights
10/24/24 Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701
10/17/24 Inozyme Pharma Announces Presentation of Interim Data from Phase 1 SEAPORT 1 Trial at the Upcoming American Society of Nephrology (ASN) Kidney Week 2024
10/07/24 Inozyme Pharma Announces Appointment of Biopharmaceutical Commercial Leader Erik Harris to its Board of Directors
09/26/24 Inozyme Pharma Presents New Data at the American Society for Bone and Mineral Research (ASBMR) 2024 Annual Meeting
08/29/24 Inozyme Pharma to Participate at the 2024 Wells Fargo Healthcare Conference
08/18/24 Jefferies Predicts up to 270% Rally for These 2 โ€˜Strong Buyโ€™ Stocks
08/11/24 Institutional owners may consider drastic measures as Inozyme Pharma, Inc.'s (NASDAQ:INZY) recent US$49m drop adds to long-term losses
08/06/24 Inozyme Pharma Reports Second Quarter 2024 Financial Results and Provides Business Highlights
07:30 AM Inozyme Pharma Publishes Preclinical Data Supporting INZ-701 as a Potential Therapy for a Broad Range of Serious Rare Diseases Impacting Bone Health and Blood Vessel Function
07/02/24 Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency
06/29/24 Why Did Inozyme Pharma, Inc. (INZY) Get a Strong Buy Rating from Analysts?
06/21/24 Inozyme Pharma Announces Presentation and Sponsored Symposium at the 11th International Conference on Childrenโ€™s Bone Health (ICCBH)
05/30/24 Inozyme Pharma to Present at the Jefferies Global Healthcare Conference
05/23/24 Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences
05/08/24 Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference
05/07/24 Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
INZY Chatroom

User Image Jajhrbdisn Posted - 2 days ago

$INZY I started a position here

User Image SanKish Posted - 3 days ago

$INZY looks like Friday had too many bullish trades for INZY. Letโ€™s hope the bottom is in and it can get going in 2025.

User Image HopefulCass Posted - 4 days ago

$INZY welcome new poster. You won't be so rare shortly.

User Image Moises_Christensen Posted - 5 days ago

$VNDA $ELDN $INZY ๐Ÿ”ฅ MYNZ ๐Ÿ”ฅ +58% yesterday n today +21% - Rumor on FDA submission soon, this time I'm believing, as TMO (Thermo Fisher) ($202.8B market cap, $42.86B 2023 revenue) backing with Vanguard and BlackRock, and DGX (Quest Diagnostics) ($17.3B market cap, $9.25B revenue), it's definitely will move upside as analysts PT updated to $120 and $440 it's insane 3000% and 12000% ๐Ÿ”ฅ๐Ÿš€๐Ÿš€๐Ÿš€

User Image bullpat Posted - 1 week ago

$INZY Started a position. Letโ€™s see how this plays outโ€ฆ

User Image metrostock Posted - 1 week ago

$INZY looking for 4 soon

User Image HopefulCass Posted - 1 week ago

$INZY it's still only me in here posting at the moment. So exciting. See you all soon folks.

User Image HopefulCass Posted - 1 week ago

$INZY several days later and nobody has posted here since my last post. I love this moment. It's the calm before the storm. Like a grand banquet just before we open the doors to guests. They will all arrive shortly.

User Image HopefulCass Posted - 1 week ago

$INZY she's sneakily moving away from her bottom at the $2.60 range. We have had consistent green days and days over $3 since then. Even this week with $XBI GETTING BUTCHERED, this is doing well. The come back is on.

User Image PLATINUM_TRADES Posted - 1 week ago

$INZY love it! ๐Ÿ๐Ÿ๐Ÿ†๐Ÿ†

User Image Quantumup Posted - 1 week ago

Raymond James๐Ÿ $INZY Buy26, says given๐Ÿ’ช๐Ÿฝ๐Ÿ”ฌinโœ‹๐Ÿฝon a straightforward primary endpoint (PPi)/productive pt ID efforts (+ inclusion in newborn screening programs), INZ-701 has the pot2replicate the success of indication-adjacent orphan blockbusters like Strensiq $AZN/Crysvita $RARE:

User Image TempusFugitGoods Posted - 1 week ago

$INZY how did the fireside chat go today?

User Image PLATINUM_TRADES Posted - 1 week ago

$INZY I told u another overnight swing winner! $3.10 possible to break now.... I love u ๐Ÿฅ‡๐Ÿฅ‡๐Ÿ๐Ÿ

User Image PLATINUM_TRADES Posted - 2 weeks ago

$INZY I told u... $3.00 cometh! ๐Ÿฅ‡๐Ÿฅ‡๐Ÿ†๐Ÿ†

User Image PLATINUM_TRADES Posted - 2 weeks ago

$INZY $2.82 to break I still think $3.00 is coming imo... Patience๐Ÿ๐Ÿ๐Ÿฅ‡๐Ÿฅ‡

User Image PLATINUM_TRADES Posted - 2 weeks ago

$INZY adds! $3.00 next imo

User Image the_real_Joker Posted - 2 weeks ago

$INZY seems the effect of the Affinity partizipation holds on, still cheep! https://investors.inozyme.com/node/9631/html

User Image crondaddy Posted - 2 weeks ago

$INZY some good price action and volume today. No news?

User Image KingNeptune Posted - 2 weeks ago

$AISP $AUPH $INZY $XFOR crushing it today. Excited for $GUTS presentation. My favorite in the weightloss sector by far. They fix the weightloss issue, not treat it with a pill or injection. Homerun in my book.

User Image Stocks4thought Posted - 2 weeks ago

$INZY INZY lost the number- what happened- anyone know? Scoop time

User Image SanKish Posted - 2 weeks ago

$INZY $CMPS $ACAD $PFE all up big today. My pharma portfolio looking good. No guarantees for the future but for now, it was good to accumulate over last 2-3 weeks.

User Image Chamcham34 Posted - 2 weeks ago

$INZY Good to see strength finally. Big green while XBI red

User Image Chamcham34 Posted - 2 weeks ago

$INZY one of these days the turn around will begin. Large institutional so when news hits it will run for days.

User Image Ontherag Posted - 2 weeks ago

$PDSB $INZY Both companies solid data and huge promise but in need of cash and currently being hit hard by the algos. INZY also has 90% institutional ownership. I believe both companies will prevail.

User Image TeeMan123 Posted - 2 weeks ago

$INZY I was drawn to this company because of its focus on ultra-rare diseases in kids. While the FDA has historically been tough on these, Vivekโ€™s comments on the DOGE program suggest this could be a prime candidate for a super-accelerated approval pathway. I think people are underestimating how much faster timelines could move under a more progressive FDA.

User Image AProst Posted - 2 weeks ago

$INZY I am listening to presentation. This guy has a confidence in his presentation that is remarkable. I dont feel like I am being sold anything, I hear a confident, direct path to success. I certainly hope patience will pay off. I have a tendency to believe in the path forward not being such a risk/gamble. We shall see.

User Image mcrotary Posted - 2 weeks ago

$INZY added for the bounce

User Image AProst Posted - 3 weeks ago

$INZY I doubt any real news presented today that we have not heard, but I am still very positive on this stock in the long term. I am just not positive on biopharma stocks in general. This bleeding is bs...but seems to be the norm in bio on even good performing phase development. I will sit on my hands and wait. Good luck.

User Image the_real_Joker Posted - 3 weeks ago

$INZY https://finance.yahoo.com/news/inozyme-pharma-participate-piper-sandler-133000676.html

User Image the_real_Joker Posted - 3 weeks ago

@Chamcham34 Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024 from 2:30-2:55pm ET https://finance.yahoo.com/news/inozyme-pharma-participate-piper-sandler-133000676.html $INZY

Analyst Ratings
Wedbush Outperform Sep 30, 24
Stifel Buy Sep 12, 24
HC Wainwright & Co. Buy Aug 8, 24
Needham Buy Aug 6, 24
Wedbush Outperform Jul 26, 24
HC Wainwright & Co. Buy Jul 2, 24
Wells Fargo Overweight May 30, 24
Needham Buy May 8, 24
Needham Buy Apr 10, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Pivotal bioVenture Partners Fu... Director Director Aug 01 Buy 4.8 833,333 3,999,998 1,571,741 08/03/23
Hopfner Robert Lorne Director Director Aug 01 Buy 4.8 833,333 3,999,998 1,571,741 08/03/23
Hopfner Robert Lorne Director Director May 11 Buy 6.37 447,932 2,853,327 3,661,518 05/15/23
Hopfner Robert Lorne Director Director Mar 29 Buy 4.5379 344,592 1,563,724 3,213,586 03/30/23
Hopfner Robert Lorne Director Director Mar 27 Buy 3.93 207,840 816,811 2,868,994 03/29/23
Bjarke Henric Bjorn SVP, COO SVP, COO Dec 15 Buy 1.39 21,500 29,885 105,441 12/19/22
Longitude Capital Partners III... 10% Owner 10% Owner Apr 19 Buy 3.69 1,355,000 4,999,950 4,174,379 04/21/22
Pivotal bioVenture Partners Fu... Director Director Apr 19 Buy 3.69 1,070,000 3,948,300 2,661,154 04/20/22
Bjarke Henric Bjorn SVP, COO SVP, COO Apr 19 Buy 3.69 27,100 99,999 80,626 04/20/22
Bolte Axel Chief Executive Offi.. Chief Executive Officer Apr 19 Buy 3.69 67,750 249,998 258,575 04/20/22
Hopfner Robert Lorne Director Director Apr 19 Buy 3.69 1,070,000 3,948,300 2,661,154 04/20/22
Subramanian Sanjay SVP, CFO SVP, CFO Apr 19 Buy 3.69 27,100 99,999 27,100 04/20/22